References
- Zulian G B. Multiple Myeloma: Clinical Evaluation of Plasma Cell Lymphoproliferative Disorders and Initial Management. Seminars in Hematology 1997; 34: 29–39
- Riccardi A, Gobbi P G, Ucci. Changing clinical presentation of multiple myeloma. European Journal of Cancer. 1991; 27: 1401–5
- Jacobson D R, Zolle‐Pazner S. Immuno‐suppression and infection in multiple myeloma. Seminars in Oncology 1986; 2: 282–292
- Ross S C, Densen P. Complement deficiency states and infection. Medicine; 1984; 63: 243–273
- Durie B GM, Salmon S E. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer; 1975; 36: 842
- Mancini G, Carbonara A D, Heremans J F. Immunochemical quantification of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–254
- Pilarski L M, Mant M J, Ruetner B A, et al. Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients. Journal of Clinical Investigation; 1984; 74: 1301–6
- Barlogie B, Epstein J, Selsanayagam P, Alexanian R. Plasma cell myeloma‐new biological insights and advances in therapy. Blood; 1989; 73: 865–879
- Schlesinger M, Broman I, Lugassy G. The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives. Leukemia; 1996; 10: 1509–13
- Barlogie B, Gale R P. Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts. American Journal of Medicine; 1992; 93: 443–450
- Jacobson D R, Zolla‐Pazner S. Immunosuppression and infection in Multiple Myeloma. Seminars in Oncology; 1986; 13: 282–290
- Kraut E H, Sagore A L. Alternative pathway of complement in Multiple Myeloma. American Journal Hematology; 1981; 11: 335–345
- Zurlo J J, Schechter G P, Fries L. Complement abnormalities in multiple myeloma. American Journal Medicine; 1989; 87: 411–420
- Pascual M, Mack Pascual S, Schifferli J A. Paraproteins and complement depletion: pathogenesis and clinical syndromes. Seminars in Hematology; 1997; 34: 40–48
- Lugassy G, Schlesinger M. The complement system in chronic lymphocytic leukemia: a possible role in autoimmune manifestations. Leukemia and Lymphoma; 1995; 18: 179–184
- Nikolova E B, Tomana M, Russel M W. All forms of humans IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen clone. Scandinavian Journal Immunology; 1994; 39: 275–280
- Lissoni P, Barni S, Cattaneo G, et al. Activation of the complement system during immunotherapy of cancer with interleukin 2‐A possible explanation of the capillary leak syndrome. International Journal of Biological Markers; 1990; 5: 195–7